Olli Pentikäinen

Title: Olli Pentikäinen: Innovator in Vascular Adhesion Protein Research

Introduction

Olli Pentikäinen is a notable inventor based in Lieto, Finland. He has made significant contributions to the field of vascular adhesion proteins, particularly through his innovative research and patent work. His expertise and dedication to advancing medical science have positioned him as a key figure in his area of specialization.

Latest Patents

Olli Pentikäinen holds a patent for "Crystalline VAP-1 and uses thereof." This invention relates to crystalline vascular adhesion protein-1 (VAP-1) and focuses on methods for utilizing structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design, and production. The patent also encompasses screening assays for the detection of these ligands and inhibitors, as well as the inhibitors identified through these assays.

Career Highlights

Pentikäinen is associated with Biotie Therapies Corporation, where he has been instrumental in advancing research related to vascular adhesion proteins. His work has contributed to the understanding of how these proteins function and their potential applications in medical treatments.

Collaborations

Some of his notable coworkers include Tiina Annamaria Salminen and Tomi Airenne. Their collaborative efforts have further enhanced the research and development initiatives at Biotie Therapies Corporation.

Conclusion

Olli Pentikäinen's contributions to the field of vascular adhesion proteins through his patent and collaborative work highlight his importance as an inventor. His innovative approaches continue to pave the way for advancements in medical science.